Cargando…
Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials
PURPOSE: To investigate the predictors of early diabetic retinopathy (DR) improvement in the RIDE/RISE (NCT00473382/NCT00473330) clinical trials. PATIENTS AND METHODS: In RIDE/RISE, adult patients with vision loss due to diabetic macular edema (DME) were randomized to monthly intravitreal ranibizuma...
Autores principales: | Singer, Michael, Liu, Mimi, Schlottmann, Patricio G, Khanani, Arshad M, Hemphill, Miranda, Hill, Lauren, Tuomi, Lisa, Haskova, Zdenka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306476/ https://www.ncbi.nlm.nih.gov/pubmed/32606578 http://dx.doi.org/10.2147/OPTH.S247061 |
Ejemplares similares
-
OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Khanani, Arshad M., et al.
Publicado: (2018) -
Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion
por: Lloyd Clark, W., et al.
Publicado: (2019) -
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial
por: Khanani, Arshad M., et al.
Publicado: (2020) -
Effect of less aggressive treatment on diabetic retinopathy severity scale scores: analyses of the RIDE and RISE open-label extension
por: Goldberg, Roger A, et al.
Publicado: (2022) -
Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration
por: Chandra, Shruti, et al.
Publicado: (2018)